welcome
Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Health

Health

TransMedics Group, Inc. (TMDX): A Bull Case Theory

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
Summary
Nutrition label

78% Informative

TransMedics Group, Inc. (TMDX) is revolutionizing the field of organ transplantation with its proprietary warm perfusion technology.

The company’s impact is especially vital considering the underwhelming organ utilization rates in the U.S. The stock has pulled back significantly from its all-time highs around $180 , now trading near $ 95 .

TransMedics Group, Inc. (TMDX) is not on our list of the 30 Most Popular Stocks Among Hedge Funds.

As per our database, 29 hedge fund portfolios held TMDX at the end of the fourth quarter which was 32 in the previous quarter .

VR Score

78

Informative language

78

Neutral language

46

Article tone

formal

Language

English

Language complexity

58

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

Source diversity

1

Affiliate links

no affiliate links